Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2016 (2016), Article ID 6016491, 6 pages
http://dx.doi.org/10.1155/2016/6016491
Research Article

Efficacy and Safety in Retinal Vein Occlusion Treated with at Least Three Consecutive Intravitreal Dexamethasone Implants

1Department of Ophthalmology, Claude Huriez Hospital, Michel Polonovski Street, 59037 Lille Cedex, France
2Department of Ophthalmology, Orleans La Source Hospital, 14 rue de l’Hôpital, 45100 Orleans, France
3Department of Biostatistics, EA2694, CHRU Lille, University of Lille, 59000 Lille, France
4Department of Ophthalmology, Saint-Vincent de Paul Hospital, Lille Catholic University, Boulevard de Belfort, BP 387, 59020 Lille Cedex, France

Received 29 October 2015; Revised 20 January 2016; Accepted 21 January 2016

Academic Editor: Stephen Charn Beng Teoh

Copyright © 2016 Julia Proença Pina et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. L. Rogers, R. L. McIntosh, L. Lim et al., “Natural history of branch retinal vein occlusion: an evidence-based systematic review,” Ophthalmology, vol. 117, no. 6, pp. 1094.e5–1101.e5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. L. McIntosh, S. L. Rogers, L. Lim et al., “Natural history of central retinal vein occlusion: an evidence-based systematic review,” Ophthalmology, vol. 117, no. 6, pp. 1113.e15–1123.e15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Noma, H. Funatsu, M. Yamasaki et al., “Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion,” Eye, vol. 22, no. 1, pp. 42–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. L. P. Aiello, R. L. Avery, P. G. Arrigg et al., “Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders,” The New England Journal of Medicine, vol. 331, no. 22, pp. 1480–1487, 1994. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-E. Chang-Lin, M. Attar, A. A. Acheampong et al., “Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant,” Investigative Ophthalmology and Visual Science, vol. 52, no. 1, pp. 80–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Lowder, R. Belfort Jr., S. Lightman et al., “Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis,” Archives of Ophthalmology, vol. 129, no. 5, pp. 545–553, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. D. S. Boyer, Y. H. Yoon, R. Belfort Jr. et al., “Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema,” Ophthalmology, vol. 121, no. 10, pp. 1904–1914, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. M. D. Medeiros, R. Navarro, J. Garcia-Arumí, C. Mateo, and B. Corcóstegui, “Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome,” Investigative Ophthalmology and Visual Science, vol. 54, no. 5, pp. 3320–3324, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Srour, G. Querques, N. Leveziel et al., “Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 251, no. 6, pp. 1501–1506, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Haller, F. Bandello, R. Belfort Jr. et al., “Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion,” Ophthalmology, vol. 117, no. 6, pp. 1134.e3–1146.e3, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Joshi, S. Yaganti, M. Gemenetzi et al., “Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed,” British Journal of Ophthalmology, vol. 97, no. 8, pp. 1040–1044, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Bezatis, G. Spital, F. Höhn et al., “Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up—the SOLO study,” Acta Ophthalmologica, vol. 91, no. 5, pp. e340–e347, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. W. J. Mayer, A. Wolf, M. Kernt et al., “Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion,” Eye, vol. 27, no. 7, pp. 816–822, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. B. D. Kuppermann, M. S. Blumenkranz, J. A. Haller et al., “Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema,” Archives of Ophthalmology, vol. 125, no. 3, pp. 309–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. T. Holladay, “Proper method for calculating average visual acuity,” Journal of Refractive Surgery, vol. 13, no. 4, pp. 388–391, 1997. View at Google Scholar · View at Scopus
  16. K. Schulze-Bonsel, N. Feltgen, H. Burau, L. Hansen, and M. Bach, “Visual acuities ‘hand motion’ and ‘counting fingers’ can be quantified with the freiburg visual acuity test,” Investigative Ophthalmology & Visual Science, vol. 47, no. 3, pp. 1236–1240, 2006. View at Publisher · View at Google Scholar
  17. G. Coscas, A. Augustin, F. Bandello et al., “Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion,” European Journal of Ophthalmology, vol. 24, no. 1, pp. 1–9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. Haller, F. Bandello, R. Belfort Jr. et al., “Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results,” Ophthalmology, vol. 118, no. 12, pp. 2453–2460, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Querques, G. Querques, R. Lattanzio et al., “Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion,” Ophthalmologica, vol. 229, no. 1, pp. 21–25, 2013. View at Publisher · View at Google Scholar
  20. I. Tservakis, C. Koutsandrea, D. Papaconstantinou, T. Paraskevopoulos, and I. Georgalas, “Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors,” Current Drug Safety, vol. 10, no. 2, pp. 145–151, 2015. View at Publisher · View at Google Scholar
  21. M. Brunner, I. Haueter, and C. Valmaggia, “Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease,” Klinische Monatsblatter fur Augenheilkunde, vol. 230, no. 4, pp. 396–400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Querques, R. Lattanzio, L. Querques et al., “Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function,” Retina, vol. 34, no. 2, pp. 330–341, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. W.-S. Yeh, J. A. Haller, P. Lanzetta et al., “Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant,” Ophthalmology, vol. 119, no. 6, pp. 1190–1198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Moisseiev, M. Goldstein, M. Waisbourd, A. Barak, and A. Loewenstein, “Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion,” Eye, vol. 27, no. 1, pp. 65–71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. E. R. James, “The etiology of steroid cataract,” Journal of Ocular Pharmacology and Therapeutics, vol. 23, no. 5, pp. 403–420, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. L. M. Meyer and C.-L. Schönfeld, “Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up,” Journal of Ocular Pharmacology and Therapeutics, vol. 29, no. 6, pp. 560–565, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Capone Jr., M. A. Singer, D. G. Dodwell et al., “Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (shasta study),” Retina, vol. 34, no. 2, pp. 342–351, 2014. View at Publisher · View at Google Scholar · View at Scopus